Published by Business Insights
Table of contents | Brochure | Order Form
Pages: 111, Coverage: Global, Published: March 2009
Single user copy: $3,835 (click here for more options)

“Biopharma company sales grew at an impressive CAGR of 15.9% over 2003-07, compared to an 8.2% CAGR for Pharma company sales… “

Large Pharma companies have become heavily dependant upon alliances and in-licensing to gain access to technologies/new molecular entities from Biopharma. This reliance has strengthened Biopharma’s bargaining
position, and is reflected in negotiation tactics which aim to expand their role beyond product discovery and development. Furthermore, recent increases in internal Biopharma consolidation are an indicator of the ability of well-established Biopharma companies to effectively compete against traditional big Pharma.

‘Evolving Trends in Biopharmaceutical Licensing’ is a new report published by Business Insights that provides a detailed analysis of licensing strategies in the biopharmaceutical industry over the 2001-08 period. This report examines the growth of the industry, deal-making trend data, drivers and challenges facing Biopharma licensing, and deal profiles for leading companies. The future prospects of the industry are assessed and the potential impact of political/regulatory factors upon licensing and alliances is identified. This report also investigates the influence of the recent upsurge in M&A activity and provides recommendations on the strategies that can sustain future growth.

Identify developments in the Pharma and Biotech licensing environment and evaluate strategies used by leading companies for in/out licensing products

Use this report to:

• Examine the licensing landscape of the biopharma industry with this report’s analysis of Biopharma and Pharma licensing and alliance activity and an examination of specific
  approaches utilized by both sectors.
• Discover the drivers and challenges facing Biopharma licensing, understand how Biopharma companies are preparing to exploit new opportunities and assess deal-making trends across clinical trials phases and key therapeutic areas.
• Evaluate the strategies of leading companies involved in biopharmaceutical licensing with this report’s analysis of deal activities amongst leading players and identify
  the changing dynamics of Biopharma/Pharma partnerships.
• Assess the future prospects of the Biopharma industry and identify how current market and political/regulatory factors will impact the dynamics of licensing and alliances, as well as potential strategies for sustaining growth.

Evolving Trends in Biopharmaceutical Licensing is available to you electronically or as a hard copy.

Our Guarantee of Quality and Value
We stand 100% behind the quality and value of our products. If you are dissatisfied, simply let us know and we will send you an immediate refund for your entire order — no questions asked.

Click here for a printable order form that you can fax or mail at a later time.